300199.SZ深圳证券交易所 · 创业板 ChiNext
Hybio Pharmaceutical 翰宇药业
Chemical Pharmaceuticals 化学制药
¥23.30−¥0.99 · −4.08%
Open 开盘
¥24.15
High 最高
¥24.25
Low 最低
¥23.23
Prev Close 昨收
¥24.29
Volume 成交量
4,395.6万股
Turnover 成交额
¥10亿
Mkt Cap 总市值
¥206亿
P/E 市盈率
161.0×
Recent Activity 近期动态All Filings 全部公告 →
16 significant filings since 30 May 2026: 12 on equity incentive, 2 on guarantee or financial assistance and 1 on earnings pre-announcement, and 1 other kind. The latest, on 21 Aug 2026: 关于2026年度向金融机构申请综合授信及担保额度的进展公告. On 11 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 54.67% to 68.42% from the same period a year earlier.
自 30 May 2026 起有 16 份重大公告：equity incentive 12 份、guarantee or financial assistance 2 份、earnings pre-announcement 1 份，另有 1 类。最新一份（21 Aug 2026）：关于2026年度向金融机构申请综合授信及担保额度的进展公告。11 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 54.67% 至 68.42%。
20.0021.0022.0023.0024.0025.0026.00
Volume 成交量
1.10亿
25 Jun17 Jul10 Aug02 Sep24 Sep
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Estimates 盈利预测
No broker EPS forecasts are held for this company.